astatine device (IMAGE)

Texas A&M University

astatine device

Caption

A team at Texas A&M University has developed an automated system for separating and shipping At-211. This patent-pending device enables the radioisotope to be purified and loaded as part of the process to incorporate it into a targeted alpha therapy drug. This new approach allows isotope producers to ship larger quantities of At-211 with less risk and less decay, further promoting its feasibility as a possible next-generation cancer treatment. 

Credit

Texas A&M University Cyclotron Institute

Usage Restrictions

free use with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.